Comprehensive Technical Guide: Neutral Borosilicate Glass Ampoules for Injectable Pharmaceuticals

Comprehensive Technical Guide: Neutral Borosilicate Glass Ampoules for Injectable Pharmaceuticals

1. Executive Summary

In the modern pharmaceutical packaging industry, ensuring drug stability, container-closure integrity (CCI), and patient safety is paramount. Neutral Borosilicate Glass Ampoules (Type I Glass) represent the gold standard for primary packaging of liquid injectables, vaccines, biological products, and sensitive chemical formulations.

Manufactured under strict compliance with Chinese National Standards (YBB00322005-2-2015) and international benchmarks (ISO 9187, USP <660>, and EP 3.2.1), PharGlass’s neutral borosilicate glass ampoules offer superior hydrolytic resistance, high mechanical strength, and customizable break options to meet global pharmaceutical manufacturing requirements.

2. Material Science: Why Neutral Borosilicate Glass (Type I)?

Pharmaceutical primary packaging directly interfaces with drug formulations throughout their shelf life. Neutral borosilicate glass (linear coefficient of expansion ≈ 5.0 × 10⁻⁶ K⁻¹) is engineered specifically to eliminate alkali leaching and thermal shock risks.

Key Material Attributes:

  • High Hydrolytic Resistance (Class HGA 1 / HC 1): Minimizes chemical reactions, pH shifts, and delamination risks (glass flake formation) when exposed to aqueous injectables.
  • Low Thermal Expansion: Withstands extreme thermal stress during depyrogenation tunnels (≥ 300°C), flame sealing, and terminal steam sterilization.
  • Superior Chemical Durability: Highly resistant to acidic, neutral, and weakly alkaline formulations, as well as light-sensitive compounds when supplied in amber glass.

3. Product Classification & Break Systems

PharGlass supplies a comprehensive portfolio of glass ampoules tailored to diverse fill-finish line automation and clinical application requirements.

A. Classification by Shape & Form Factor

  • Form B (Cut-stem / Standard): Widely utilized for standard liquid filling and automated flame sealing operations.
  • Form C (Open-funnel): Engineered with a widened funnel mouth to reduce liquid splash and contamination during high-speed filling.
  • Form D (Closed-stem / Sealed): Delivered pre-sealed to maintain interior cleanliness prior to washing and sterilization.
  • Form E (Specialized Custom Shapes): Designed for custom medical devices, cartridges, or specialized drug delivery mechanisms.

B. Classification by Opening Mechanism (Easy-Break Systems)

To ensure safety in clinical environments and minimize particle generation upon opening, ampoules feature three primary breaking technologies:

  1. One-Point Cut (OPC): Features a micro-score on the ampoule stem combined with a color dot (d7). Pressure applied opposite to the dot yields a clean, effortless break.
  2. Color Ring Break (CBR): Employs a continuous color ring painted around the neck with controlled tensile strain, allowing 360° breakability.
  3. Score Ring / Ring Break: A continuous geometric score around the neck for uniform opening force without color identification.

4. Dimensional Specifications & Technical Tolerances (YBB00322005-2-2015)

Precision manufacturing is essential to prevent jamming on automated filling lines and to guarantee hermetic seals. All parameters conform strictly to standard YBB00322005-2-2015.

Crucial Engineering Constraint: For all compliant ampoules, dimensional ratios must satisfy:

d1 > d3 > d2 > d4

(Body Outer Diameter > Bulb Outer Diameter > Neck Outer Diameter > Stem Outer Diameter)

Technical Specification Matrix (Unit: mm)

CapacityBody OD (d1)Neck OD (d2)Bulb OD (d3)Stem OD (d4)Color Dot Dia. (d7)Total Height (h1)Base to Neck (h4)Base to Meas. Pt. (h5)Base to Shoulder (h6)Base to Color Pt. (h9)Stem Wall (S2) MinBase Wall (S3) MinRunout (t) MaxBase Thickness MinMid-Neck Vol. (ml)
1ml10.00 ± 0.266.3 ± 0.87.8 ± 1.05.0 ± 0.62.0 ± 0.560.00 ± 1.025.00 ± 1.057.0021.0031.500.200.201.01.01.5
2ml11.50 ± 0.267.0 ± 0.88.5 ± 1.05.5 ± 0.62.0 ± 0.570.00 ± 1.036.50 ± 1.067.0032.0043.000.200.201.01.02.9
3ml13.30 ± 0.308.0 ± 0.89.2 ± 1.05.8 ± 0.62.0 ± 0.570.00 ± 1.036.50 ± 1.067.0032.0043.000.200.201.01.04.0
5ml16.00 ± 0.308.2 ± 1.010.0 ± 1.06.0 ± 0.62.0 ± 0.587.00 ± 1.043.00 ± 1.084.0038.5050.500.200.301.71.36.8
10ml18.40 ± 0.358.8 ± 1.211.0 ± 1.06.8 ± 0.82.0 ± 0.5102.0 ± 1.058.50 ± 1.299.0053.5066.500.250.301.71.312.3
20ml22.00 ± 0.3510.5 ± 1.213.0 ± 1.07.3 ± 1.02.0 ± 0.5126.0 ± 1.376.50 ± 1.5123.0068.0085.000.300.352.41.323.5
25ml22.00 ± 0.3510.5 ± 1.213.0 ± 1.07.3 ± 1.02.0 ± 0.5144.0 ± 1.394.50 ± 1.5141.0086.00103.000.300.352.41.323.5

5. Quality Control & Manufacturing Process

At PharGlass, neutral borosilicate glass ampoules undergo strict multi-stage quality assurance protocols to comply with cGMP guidelines:

  1. Precision Tubing Selection: High-grade 5.0 neutral borosilicate glass tubes with uniform wall thickness distribution are used as raw input.
  2. Automated Forming & Annealing: Advanced multi-station rotary forming machines guarantee tight dimensional tolerances. Post-forming stress relief annealing removes residual mechanical stress to prevent spontaneous cracking.
  3. 100% Camera Inspection (Vision Systems): Automated optoelectronic detection systems continuously screen for dimensional deviations, cosmetic defects, black spots, and glass chips.
  4. Breaking Force Testing: Rigorous sampling tests verify that breaking force falls within regulatory parameters (typically 25 N to 60 N depending on neck diameter), preventing accidental breakage during transport while ensuring effortless opening by healthcare providers.

6. Regulatory Compliance & Global Standards

PharGlass packaging products are supported by comprehensive regulatory documentation, enabling seamless drug registration across global markets (FDA, EMA, NMPA):

  • China National Standard: YBB00322005-2-2015
  • International Standards: ISO 9187-1 / ISO 9187-2
  • Pharmacopeial Compliance: USP <660> (Containers – Glass), EP 3.2.1 (Glass Containers for Pharmaceutical Use), JP 7.01
  • Certifications: ISO 15378 (Primary packaging materials for medicinal products), ISO 9001, ISO 14001

7. Applications & Formulations

Neutral borosilicate glass ampoules are recommended for formulations requiring 100% tamper-evident, hermetically sealed closure:

  • Liquid Vaccines and Toxoids
  • Highly Potent Injectable Drugs (Oncology, Anesthetics)
  • Biologicals, Blood Products, and Sera
  • Freeze-dried / Lyophilized Drug Base (stem sealing options)
  • Diagnostic Reagents and Contrast Media

8. Conclusion & OEM/ODM Inquiries

PharGlass provides customized OEM/ODM packaging solutions tailored to your specific drug product compatibility and filling machinery requirements. From custom neck printing and break force tuning to full DMF documentation support, our technical engineering team is ready to assist your team.

Contact PharGlass Engineering Team: sales@pharglass.com

Request Technical Samples & DMF Documentation: Visit www.pharglass.com


en_USEN